HIV

Amid protests over alleged shortage of antiretroviral drugs, official sources have said there is adequate stock nationally for around 95 per cent of 'People Living with HIV' who are on first and second line ARV regimens in the country.…

Homegrown pharma major and its partner Drugs for Neglected Diseases initiative (DNDi) on Tuesday announced the launch of a 4-in-1 antiretroviral treatment for children living with HIV in South Africa. South African Health Products…